A fully automated one-pot synthesis of 6-[F-18]fluoro-L-DOPA, an important radiopharmaceutical for studies on the presynaptic dopamine metabolism with positron emission tomography,is described. 6-[F-18]Fluoro-L-DOPA was prepared in high radiochemical yield (33 +/- 4%, c.f.d.) and radiochemical purity (> 99%) in 45 min synthesis time by a fluorodestannylation reaction, followed by acidic removal of the protecting groups. CFCl3 was found to be a better solvent for the fluorodestannylation reaction than CHCl3 or acetonitrile. In CFCl3, [F-18]F-2 was a superior fluorinating agent over [F-18]acetyl hypofluorite. (C) 1999 Elsevier Science Ltd. All rights reserved.</p
The (18)F-labeled aromatic amino acid 6-fluoro-3,4-dihydroxy-L-phenylalanine (6-(18)F-fluoro-L-DOPA)...
METHODS: A trimethylammonium veratraldehyde triflate was synthesized and used as a precursor for the...
Recently a novel method for the preparation of F-18-labeled arenes via oxidative [F-18] fluorination...
A fully automated one-pot synthesis of 6-[F-18]fluoro-L-DOPA, an important radiopharmaceutical for s...
The neurotracer 6-[18F] FDOPA has been, for many years, a powerful tool in PET imaging of neuropsych...
This report critically appraises methods for the synthesis of 6-[18F]fluoro-l-3,4-dihydroxyphenylala...
In nuclear medical diagnosis, 6-[$^{18}$F]fluoro-L-3,4-dihydroxyphenylalanine (6-[$^{18}$F]fluoro-LD...
This paper describes the preparation of 6-[18F]fluoro-L-dopa by a no-carrier-added method based on t...
6-[$^{18}$F]Fluoro-L-3,4-dihydroxyphenylalanine (6-[$^{18}$F]fluoro-L-DOPA), an analogue of L-DOPA, ...
Das L-DOPA-Analogon 6-["1"8F]Fluor-L-3,4-dihydroxyphenylalanin (6-["1"8F]Fluor-L...
[18F]F-DOPA is an important radiotracer that is used in the diagnosis of Parkinson's disease and neu...
Background [F-18]MC225 is a radiotracer for imaging P-glycoprotein (P-gp) function at the blood-brai...
6-18F-fluoro-L-dopa (18F-FDOPA) has proven to be a useful radiopharmaceutical for the evaluation of ...
There are an estimated 1–2 million victims of Parkinson\u27s disease (PD) in the United States today...
6-l-[F-18]Fluoro-m-tyrosine (6-l-[F-18]FMT) represents a valuable alternative to 6-l-[F-18]FDOPA whi...
The (18)F-labeled aromatic amino acid 6-fluoro-3,4-dihydroxy-L-phenylalanine (6-(18)F-fluoro-L-DOPA)...
METHODS: A trimethylammonium veratraldehyde triflate was synthesized and used as a precursor for the...
Recently a novel method for the preparation of F-18-labeled arenes via oxidative [F-18] fluorination...
A fully automated one-pot synthesis of 6-[F-18]fluoro-L-DOPA, an important radiopharmaceutical for s...
The neurotracer 6-[18F] FDOPA has been, for many years, a powerful tool in PET imaging of neuropsych...
This report critically appraises methods for the synthesis of 6-[18F]fluoro-l-3,4-dihydroxyphenylala...
In nuclear medical diagnosis, 6-[$^{18}$F]fluoro-L-3,4-dihydroxyphenylalanine (6-[$^{18}$F]fluoro-LD...
This paper describes the preparation of 6-[18F]fluoro-L-dopa by a no-carrier-added method based on t...
6-[$^{18}$F]Fluoro-L-3,4-dihydroxyphenylalanine (6-[$^{18}$F]fluoro-L-DOPA), an analogue of L-DOPA, ...
Das L-DOPA-Analogon 6-["1"8F]Fluor-L-3,4-dihydroxyphenylalanin (6-["1"8F]Fluor-L...
[18F]F-DOPA is an important radiotracer that is used in the diagnosis of Parkinson's disease and neu...
Background [F-18]MC225 is a radiotracer for imaging P-glycoprotein (P-gp) function at the blood-brai...
6-18F-fluoro-L-dopa (18F-FDOPA) has proven to be a useful radiopharmaceutical for the evaluation of ...
There are an estimated 1–2 million victims of Parkinson\u27s disease (PD) in the United States today...
6-l-[F-18]Fluoro-m-tyrosine (6-l-[F-18]FMT) represents a valuable alternative to 6-l-[F-18]FDOPA whi...
The (18)F-labeled aromatic amino acid 6-fluoro-3,4-dihydroxy-L-phenylalanine (6-(18)F-fluoro-L-DOPA)...
METHODS: A trimethylammonium veratraldehyde triflate was synthesized and used as a precursor for the...
Recently a novel method for the preparation of F-18-labeled arenes via oxidative [F-18] fluorination...